• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Amarantus Bioscience Holdings Inc

+ Add to Watchlist


0.0879 USD 0.0050 6.03%

As of 17:10:02 ET on 12/24/2014.

Snapshot for Amarantus Bioscience Holdings Inc (AMBS)

Open: 0.0870 Day's Range: 0.0851 - 0.0890 Volume: 4,827,990
Previous Close: 0.0829 52wk Range: 0.0489 - 0.1960 1-Yr Rtn: +62.78%

Stock Chart for AMBS

No chart data available.
  • AMBS:US 0.0879
  • 1D
  • 1M
  • 1Y
Interactive AMBS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AMBS

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0470
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 70.29
Shares Outstanding (M) 799.65
30 Day Average Volume 3,165,774
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AMBS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AMBS

Amarantus Bioscience Holdings, Inc. is a biotechnology holding company. The Company, through its subsidiaries, certain biologics surrounding the intellectual property and proprietary technologies it owns to treat and/or diagnose Parkinson's disease, traumatic brain Injury, Ischemic heart disease and other human diseases.

Gerald E CommissiongPresident/CEO/COORobert FarrellChief Financial Officer
John W CommissiongChief Scientific Ofcr/Co-FounderElise BrownellSenior VP:Ops & Project Mgmt
More Company Profile & Key Executives for AMBS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil